What happened
The Food and Drug Administration Thursday approved a new class of pain pill that is not addictive like opioids. Suzetrigine, being sold as Journavx by Vertex Pharmaceuticals, is the first new pharmaceutical treatment for pain to win FDA approval in more than 20 years.
Who said what
Opioids work by binding to receptors in the brain that receive pain signals from nerves around the body, but "those chemical interactions also give rise to opioids' addictive effects," The Associated Press said. But while prescription opioids have helped fuel an epidemic of addiction and overdoses, suzetrigine "works differently," intercepting pain signals before they reach the brain.
In two clinical trials submitted by Vertex, suzetrigine was more effective than a placebo at treating short-term pain in people recovering from stomach and foot surgery, and on par with a combined acetaminophen-hydrocodone pill, like Vicodin.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What next?
Journavx was approved to treat acute pain in adults. But at a list price of $15.50 a pill, it "faces some hurdles in winning over physicians, hospitals and insurance companies," The Washington Post said. The new painkiller is promising because "there are a number of people who, once they have an opioid, want an opioid constantly," University of Washington pain expert Dr. John Loeser said to The New York Times. But acetaminophen-opioid pills are "dirt cheap."
-
Nepal chooses toddler as its new ‘living goddess’Under the Radar Girls between two and four are typically chosen to live inside the temple as the Kumari – until puberty strikes
-
October 5 editorial cartoonsCartoons Sunday's political cartoons include half-truth hucksters, Capitol lockdown, and more
-
Jaguar Land Rover’s cyber bailoutTalking Point Should the government do more to protect business from the ‘cyber shockwave’?
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
‘Nightmare bacteria’ are rapidly spreadingUnder the radar The infections are largely resistant to antibiotics
-
Kissing bug disease has a growing presence in the USThe explainer The disease has yielded a steady stream of cases in the last 10 years
-
Climate change is making us eat more sugarUnder the radar Sweets make the heat feel more manageable
-
Trump makes unmoored claims on Tylenol and autismSpeed Read No causal relationship has been established between autism and acetaminophen use during pregnancy
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
The UK’s opioid crisis: why the stats don’t add upThe Explainer A new report has revealed that the UK’s total of opioid-related deaths could be much greater than official figures show
